Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteneurotrack.com
Twitter@Neurotrack
CategoryBioTech
Emailfounders@neurotra...
Employees
Founded2012
DescriptionEarly Diagnosis of Alzheimer's

Offices

Richmond, USA
4200 Grove Avenue
Richmond, VA, 23221
USA

Funding

TOTAL $2.09M
FUNDING TOTAL $2.09M
Seed, 5/2013
$90k
Series A, 9/2013
Founders Fund
The Social+Capital Partnership
Rock Health
$2M

Tags

Neurotrack

Neurotrack’s technology can diagnose Alzheimer’s Disease up to six years before symptoms occur. Based on ground-breaking research, it enables pharmaceutical companies and researchers to recruit qualified candidates for clinical trials, and more effectively measure drug efficacy, speeding up drug discovery and development.

Neurotrack is also becoming the standard for early clinical screening of Alzheimer’s and dementia related disorders.

Recent Milestones

Videos

Screenshots

Neurotrack screenshot
Above: Neurotrack Screenshot -- #1
Uploaded: 9/26/13

Sources

  1. Neurotrack nabs $90K for its tech that predicts the onset of Alzheimer’s (exclusive) (venturebeat.com) [edit]
  2. Neurotrack Raises $2M From Founders Fund, Social+Capital To Predict And Diagnose The Onset Of Alzheimer’s Disease (techcrunch.com) [edit]
Edit This Page
Last Edited 2/5/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy